IRIS
ZENTILIN, PATRIZIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 16.915
Totale 16.915
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 16.915
Totale 16.915
Salva come PNG Salva come JPEG
Città #
Genova 12.851
Rapallo 1.742
Genoa 1.432
Vado Ligure 856
Bordighera 34
Totale 16.915
Salva come PNG Salva come JPEG
Nome #
Hepatobiliary and Pancreatic: A rare cause of portal hypertension. 173
Characteristics of gastro-esophageal reflux episodes in Barrett's esophagus, erosive esophagitis and healthy volunteers 169
Not All Patients With Non-erosive Reflux Disease Share Psychological Distress as Main Mechanism of Disease. 164
The relevance of symptom association analysis in GORD patients undergoing anti-reflux surgery 161
Time pattern of gastric acidity in Barrett's esophagus 158
Circadian pattern of intragastric acidity in patients with non-erosive reflux disease (NERD) 150
Alginate controls heartburn in patients with erosive and nonerosive reflux disease. 147
A pharmacodynamic study of two omeprazole regimens suitable for long-term treatment of duodenal ulcer. 145
The added value of impedance-pH monitoring to Rome III criteria in distinguishing functional heartburn from non-erosive reflux disease. 143
Reassessment of the diagnostic value of histology in patients with GERD, using multiple biopsy sites and an appropriate control group 141
Improvement in esophageal motor abnormalities in systemic sclerosis patients treated with cyclosporine: comment on the article by Clements et al. 141
Oesophageal motility and bolus transit abnormalities increase in parallel with the severity of gastro-oesophageal reflux disease. 141
Advancements in the use of manometry and impedance testing for esophageal functional disorders 140
Microscopic esophagitis distinguishes patients with non-erosive reflux disease from those with functional heartburn. 138
Outcome of nonerosive gastro-esophageal reflux disease patients with pathological acid exposure. 137
Proton pump inhibitors: use and misuse in the clinical setting 135
Impedance-pH reflux patterns can differentiate non-erosive reflux disease from functional heartburn patients. 135
New insight in the mechanism of omeprazole antimicrobial combinations to eradicate Helicobacter pylori. 131
A comparison of the effects on intragastric acidity of bedtime or dinnertime administration of a once daily dose of famotidine. 131
A review of pharmacotherapy for treating gastroesophageal reflux disease (GERD) 131
Esophageal biopsies in the management of GERD: complementary tool for many but not for all. 130
NERD: an umbrella term including heterogeneous subpopulations. 129
A safety review of proton pump inhibitors to treat acid-related digestive diseases 129
Antimony and glass pH electrodes can be used interchangeably in 24-hour studies of gastric acidity. 128
Once and twice daily doses of H2 antagonists revisited, using continuous intragastric pH monitoring. 128
Cyclosporin A and iloprost treatment of systemic sclerosis: clinical results and interleukin-6 serum changes after 12 months of therapy. 128
A comparison between sodium alginate and magaldrate anhydrous in the treatment of patients with gastroesophageal reflux symptoms. 128
Endotherapy for and tailored approaches to treating GERD, and refractory GERD 127
Microscopic esophagitis in gastro-esophageal reflux disease: individual lesions, biopsy sampling, and clinical correlations 125
Cell proliferation of squamous epithelium in gastro-oesophageal reflux disease: correlations with clinical, endoscopic and morphological data 125
An evaluation of the antireflux properties of sodium alginate by means of combined multichannel intraluminal impedance and pH-metry. 124
Are duodenal ulcer seasonal fluctuations paralleled by seasonal changes in 24-hour gastric acidity and Helicobacter pylori infection? 124
Effect of gastric acid suppression on 13C-urea breath test: comparison of ranitidine with omeprazole. 123
Esophageal acid exposure still plays a major role in patients with NERD. 122
Negative effect of ranitidine on the results of urea breath test for the diagnosis of Helicobacter pylori 121
Drugs for improving esophageal mucosa defense: Where are we now and where are we going? 121
Microscopic Esophagitis is More Frequent in Patients With pH-Positive Non-Erosive Reflux Disease and Hypersensitive Esophagus Than in Those With Functional Heartburn: A Study Using Impedance-pH and Optical Microscopy. 120
Antisecretory effects of three omeprazole regimens for maintenance treatment in duodenal ulcer. 120
Characteristics of reflux episodes and symptom association in patients with erosive esophagitis and nonerosive reflux disease: study using combined impedance-pH off therapy. 118
24-hour gastric pH and extent of duodenal gastric metaplasia in Helicobacter pylori-positive patients. 118
Helicobacter pylori and tolerance to H2-blockers. 118
Innovative techniques in evaluating the esophagus; imaging of esophageal morphology and function; and drugs for esophageal disease. 118
The relevance of weakly acidic reflux in patients with Barrett's esophagus. 118
Helicobacter pylori infection is not involved in the pathogenesis of either erosive or non-erosive gastro-oesophageal reflux disease. 117
Reduction of hexavalent chromium by fasted and fed human gastric fluid. I. Chemical reduction and mitigation of mutagenicity 117
Absence of tolerance in duodenal ulcer patients treated for 28 days with a bedtime dose of roxatidine or ranitidine. 116
Circadian acidity pattern in prepyloric ulcers: a comparison with normal subjects and duodenal ulcer patients. 115
Gastro-oesophageal reflux and gastric aspiration in idiopathic pulmonary fibrosis patients. 114
A 10-day levofloxacin-based therapy in patients with resistant Helicobacter pylori infection: a controlled trial 113
Clinical relevance of sampling rate in the characterization and analysis of 24-hour gastric acidity. A report on 413 cases. 113
Comparable Helicobacter pylori eradication rates obtained with 4- and 7-day rabeprazole-based triple therapy: a preliminary study 110
The role of Acid in functional dyspepsia. 110
Is Helicobacter pylori infection a risk factor for disease severity in rheumatoid arthritis? 109
Partial regression of Barrett's esophagus by long-term therapy with high-dose omeprazole 108
Achalasia with Dense Eosinophilic Infiltrate Responding To Steroidal Treatment. 107
Air swallowing can be responsible for non-response of heartburn to high-dose proton pump inhibitor. 107
Comparison of the effects of placebo, ranitidine, famotidine and nizatidine on intragastric acidity by means of continuous pH recording. 107
Lactulose breath test to assess oro-cecal transit delay and estimate esophageal dysmotility in scleroderma patients. 106
Nonerosive reflux disease and functional heartburn are clearly separate entities. 106
Eradication of Helicobacter pylori may reduce disease severity in rheumatoid arthritis. 105
Esophageal acid exposure still plays a major role in patients with NERD. 105
Circadian gastric acidity in Helicobacter pylori positive ulcer patients with and without gastric metaplasia in the duodenum. 105
The effects of omeprazole 20 and 40 mg twice daily on intragastric acidity in duodenal ulcer patients. 104
Ulcer healing: does omeprazole efficacy depend on daytime or 24-hour acid inhibition? 103
Comment to "current applications of evolving methodologies in gastroesophageal reflux disease testing". 103
Relevance of measuring substances in bronchoalveolar lavage fluid for detecting aspiration-associated extraesophageal reflux disease 103
Pathophysiological characteristics of patients with non-erosive reflux disease differ from those of patients with functional heartburn. 102
Non-erosive reflux disease is more complex than negative endoscopy only. 102
Is gastric acid hypersecretion the only reason for refractory gastroesophageal reflux disease? 101
Stool antigen assay (HpSA) is less reliable than urea breath test for post-treatment diagnosis of Helicobacter pylori infection. 101
Normal values of 24-h ambulatory intraluminal impedance combined with pH-metry in subjects eating a Mediterranean diet. 101
The impact of antibiotic resistance on the efficacy of three 7-day regimens against Helicobacter pylori. 100
Gastroesophageal reflux and pulmonary fibrosis in scleroderma: a study using pH-impedance monitoring. 99
Low bedtime doses of H2-receptor antagonists for acute treatment of duodenal ulcer. 99
MIB-1 Proliferation Index of squamous epithelium in gastroesophageal reflux disease. Correlations with clinical, Endoscopic and Morphological data. 99
Defining esophageal landmarks, gastroesophageal reflux disease, and Barrett's esophagus. 99
The appropriate use of proton-pump inhibitors 99
Antisecretory effect of three premeal doses of cimetidine 400 mg versus a single morning dose of omeprazole 20 mg: pathophysiological implications for duodenal ulcer treatment. 98
Esophagogastric junction morphology is associated with a positive impedance-pH monitoring in patients with GERD 98
Functional testing: pharyngeal pH monitoring and high-resolution manometry. 98
Once-Daily Bedtime Dose of Roxatidine and Ranitidine in Acute Duodenal Ulcer: A Combined Assessment of Acid Inhibitory Activity and Healing Rate. 97
Studies on factors predicting GORD response to proton-pump inhibitors: NERD subpopulations need to be analysed separately. 97
Pathophysiological studies are mandatory to understand the benefit of proton pump inhibitors in patients with idiopathic pulmonary fibrosis 96
Low Fibrinogen Levels Are Associated with Bleeding After Varices Ligation in Thrombocytopenic Cirrhotic Patients 96
Gastric aspiration versus antimony and glass pH electrodes. A simultaneous comparative in vivo study. 95
Esophageal baseline impedance levels allow the identification of esophageal involvement in patients with systemic sclerosis 95
Optimal duration of therapy combining ranitidine bismuth citrate with clarithromycin and metronidazole in the eradication of Helicobacter pylori infection. 94
Combined multichannel intraluminal impedance and pH-metry: a novel technique to improve detection of gastro-oesophageal reflux literature review. 94
Epidemiology and natural history of gastroesophageal reflux disease 94
Comparison of 24-h control of gastric acidity by three different dosages of pantoprazole in patients with duodenal ulcer. 93
The reason for failure of on-demand PPI therapy in NERD patients. 93
It is time to plan clinical trials on true NERD patients. 93
Carditis in patients with gastro-oesophageal reflux disease: results of a controlled study based on both endoscopy and 24-h oesophageal pH monitoring. 91
Duodenal ulcer resistant to usual omeprazole dose. 91
Light microscopy is useful to better define NERD and functional heartburn. 91
24-hour study of gastric acidity in normal subjects and in cholecystectomized patients using continuous pH monitoring. 90
Functional heartburn has more in common with functional dyspepsia than with non-erosive reflux disease. 89
Pathophysiology, diagnosis, and pharmacological treatment of gastro-esophageal reflux disease 89
Duration of acid suppression in H2-antagonist nonresponders. 87
Single morning and nightly doses of ranitidine 300 mg: an appraisal of their antisecretory effects by continuous pH monitoring. 87
Totale 11.504
Salva come PNG Salva come JPEG
Categoria #
all - tutte 51.476
article - articoli 45.234
book - libri 367
conference - conferenze 595
curatela - curatele 0
other - altro 4.601
patent - brevetti 0
selected - selezionate 0
volume - volumi 679
Totale 102.952
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.814 0 0 0 0 434 470 693 324 426 789 467 211
2020/20211.391 72 155 132 115 71 127 88 149 147 138 97 100
2021/20222.102 107 156 179 282 75 144 163 405 82 210 65 234
2022/20232.094 223 130 21 190 442 312 1 167 367 13 203 25
2023/20241.019 49 123 24 115 94 157 64 49 59 21 83 181
2024/2025987 160 253 152 206 216 0 0 0 0 0 0 0
Totale 17.127